Indications -- Asthma/Allergy | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Indications -- Asthma/Allergy

An SI Board Since March 2001

Posts	SubjectMarks	Bans
86	25	0

Emcee: scaram(o)uche	Type: Moderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
61	ah........... thanks. (ok, chat finished) Best! Rick	scaram(o)uche	-	6/1/2005
60	analyalyly is the RNAi co. anadys is a small mol anti-viral co, with an oral	keokalani'nui	-	6/1/2005
59	No, not in detail. They're a RNAi company, correct? Or is that Analayanaly	scaram(o)uche	-	6/1/2005
58	You ever looked at anadys' TLR7 program?	keokalani'nui	-	6/1/2005
57	(OT) <i>There are simply degrees of "good", however.</i>	nigel bates	-	6/1/2005
56	Certainly. And it's probably a very good one. There are simply degrees of	scaram(o)uche	-	6/1/2005
55	<i>Novartis should first learn about BioSeek</i> Doesn't Novart	nigel bates	-	6/1/2005
54	Cart before horse, Novartis should first learn about BioSeek, and <i>then&	scaram(o)uche	-	6/1/2005
53	Hybridon Announces Collaboration to Develop Immune Modulatory (IMO) Compounds fo	nigel bates	-	6/1/2005
52	AVANIR's Novel Orally Active Asthma/Allergy Drug Candidate Subject of Journa	keokalani'nui	-	12/16/2004
51	Nature Reviews - Drug Discovery features this month an extensive free review of	Icebrg	-	10/1/2004
50	Stanford/Packard Researchers Identify T Cell that Relieves Asthma in Mice Sunday	keokalani'nui	-	9/26/2004
49	62 percent of frequent antihistamine users did not test positive for allergies P	Icebrg	-	6/28/2004
48	ALTANA Pharma Receives First Approval to Market Alvesco-R- -Ciclesonide- Friday	nigel bates	-	2/27/2004
47	ALTANA will Submit Daxas-R (PDE4-inhibitor) for European Approval in February 20	nigel bates	-	12/19/2003
46	Hunter-Fleming / EtxB (just parking): HF 1020 (the non-enterotoxic B-subunit of	nigel bates	-	9/8/2003
45	FDA Advisory Committee Unanimously Recommends Approval of Xolair Thursday May 15	Icebrg	-	5/15/2003
44	Xolair shown to benefit some asthma patients--FDA Wednesday May 14, 11:05 am ET	scaram(o)uche	-	5/14/2003
43	New asthma drug could face obstacles Therapy may have trouble gaining acceptance	Icebrg	-	5/14/2003
42	In Play® 1:28 pm Tanox lower following Adams Harkness comments (TNOX) 12.47	Icebrg	-	4/4/2003
41	NKT Cells Critical for Asthma Development 3/31/2003 -- A subset of immune cell	nigel bates	-	4/1/2003
40	[AVN - IgE & Th2] >>SAN DIEGO, March 17 /PRNewswire-FirstCall/ -- AVA	tuck	-	3/27/2003
39	Genentech, Novartis and Tanox Announce FDA Advisory Committee Review of Xolair -	scaram(o)uche	-	3/27/2003
38	Dynavax Initiates Phase II Human Trial of ISS for Asthma BERKELEY, Calif., Feb.	nigel bates	-	2/11/2003
37	GSK / Theravance alliance ($50m upfront) SOUTH SAN FRANCISCO, Calif. and LONDON	nigel bates	-	1/6/2003

Go to reply# or date (mm/dd/yy):